Successful Outcomes in Patients with Exudative Age Related Macular Degeneration

On-Demand Webinar

Optimize the experience for your patients with Age Related Macular Degeneration (AMD) by understanding dosing frequencies, utilizing the treat-and-extend approach, and developing a standard follow-up protocol.

After completing this activity, the participant should be better able to:

  • Develop a standard follow-up protocol to manage patients with exudative AMD from diagnosis through long-term care
  • Determine how frequency of dosing differs between patients, identifying patients who can achieve 12-week dosing intervals with currently available therapies
  • Understand the utility of the treat-and-extend approach to anti-vascular endothelial growth factor (VEFG) therapy based on measurable visual and anatomic parameters
  • Identify factors that may affect patient response to therapy and select anti-VEGF therapy appropriately
  • Identify best practices for optimizing the patient experience through AMD treatments and discuss lean practice models for delivery of care given the frequency of visits

Faculty Panel:

Singh

Rishi P. Singh, MD
Chair & Moderator

Kaiser

Peter K. Kaiser, MD

Kim

Judy E. Kim, MD
 

Khurana

Rahul N. Khurana, MD
 

Rosenfeld

Philip J. Rosenfeld, MD, PhD